,outcome,arm 1,arm 2
0,intervention,"ixabepilone + EMP arm, ixabepilone arm",
0,,"13 %, 22 %, 29 %, 9 %",NR
0,"Grades 3 and 4 toxicities experienced by more than 5 % of patients, total study group",6 %,6 %
